Alcon (ALC) Valuation Rank


ALC Alcon Inc ALC
71 GF Score
Price $67.93
GF Value $89.75
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Alcon Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Alcon Valuation Rank Related Terms

ALC
71GF Score
Alcon Inc ALC
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alcon (ALC) Overvalued in 2026?

Based on GuruFocus' analysis, Alcon stock appears to be undervalued. The current stock price of $67.93 is trading 24.3% below its estimated GF Value™ of $89.75. GuruFocus considers Alcon to be Modestly Undervalued.

Key valuation signals for ALC:

  • Valuation Rank:
  • GF Value™: $89.75 vs. price of $67.93 (24.3% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alcon Business Description

Address Chemin de Blandonnet 8, Vernier, Geneva, CHE, 1214
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
71GF Score

Get the complete analysis for ALC

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$67.93
Price
$89.75
GF Value